Skip to main content
Displaying 61 - 72 of 93
Display:
12
24
48
Viral Hepatitis
Audience Q&A and Close
Webcasts
View
Viral Hepatitis
Case studies – ‘Best Practices for Optimizing HCV Care’
Webcasts
View
Viral Hepatitis
Case studies – ‘Best Practices for Optimizing HCV Care’
Webcasts
View
Metabolism, Alcohol & Toxicity
Why we need to talk about NASH
Webcasts
View
Metabolism, Alcohol & Toxicity
Hepatic consequences of metabolic dysregulation: NAFLD and NASH
Webcasts
View
Metabolism, Alcohol & Toxicity
Looking ahead: how to identify high-risk patients
Webcasts
View
Metabolism, Alcohol & Toxicity
Navigating the NASH healthcare system: global insights and challenges (panel discussion and Q&A)
Webcasts
View
Metabolism, Alcohol & Toxicity
The NASH treatment pipeline: focus on anti-metabolic approaches
Webcasts
View
Metabolism, Alcohol & Toxicity
Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction
Webcasts
View
Cirrhosis & Complications
Meeting the challenge of severe thrombocytopenia with TPO-RAs
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Page
3
Page
4
Page
5
Current page
6
Page
7
Page
8
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy